AlphaCentric Advisors »

Indivior shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Indivior (INDV) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Indivior

Tip: Access up to 7 years of quarterly data

All positions including Indivior held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.4M 243k 9.75

More positions owned by AlphaCentric Advisors

Rithm Capital Corp Com New (RITM)
Harmony Biosciences Hldgs In (HRMY)
Galapagos Nv Spon Adr (GLPG)
Merck & Co (MRK)
Ellington Financial Inc ellington financ (EFC)
Neurocrine Biosciences (NBIX)
MGIC Investment (MTG)
Argenx Se Sponsored Adr (ARGX)
Indivior Ord (INDV)
Dynex Cap (DX)
BioMarin Pharmaceutical (BMRN)
Sarepta Therapeutics (SRPT)
Dynavax Technologies Corp Com New (DVAX)
United Therapeutics Corporation (UTHR)
Redwood Trust (RWT)

View all positions for AlphaCentric Advisors

Top funds holding Indivior

Two Seas Capital
Oaktree Capital Management
Deerfield Management Company
Vanguard Group
Barclays
Bank of America Corporation
Goldman Sachs Group
Liontrust Investment Partners
Scopia Management
Leucadia National Corporation
Newtyn Management
Credit Agricole
Krensavage Asset Management
VR Advisory Services
CenterBook Partners

View all funds holding Indivior